Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
ACMG Member LoginAre you an ACMG Member? Sign in for online access.
Subscribe:Subscribe to Genetics in Medicine
- Cancer susceptibility gene mutations in individuals with colorectal cancer.J Clin Oncol. 2017; 35: 1086-1095https://doi.org/10.1200/JCO.2016.71.0012
National Comprehensive Cancer Network. NCCN Guidelines: Genetic/Familial High-Risk Assessment: Colorectal. version 1. 2022. National Comprehensive Cancer Network. Published June 8, 2022. Accessed July 11, 2022. https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf
- A counseling framework for moderate-penetrance colorectal cancer susceptibility genes.Genet Med. 2018; 20: 1324-1327https://doi.org/10.1038/gim.2018.12
- Colorectal cancer incidence patterns in the United States, 1974-2013.J Natl Cancer Inst. 2017; 109: djw322https://doi.org/10.1093/jnci/djw322
- Screening for colorectal cancer: US Preventive Services Task Force recommendation statement.JAMA. 2021; 325 (Published correction appears in JAMA. 2021;326(8):773): 1965-1977
- Updates on age to start and stop colorectal cancer screening: recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer.Gastroenterology. 2022; 162 (Published correction appears in Gastroenterology. 2022;163(1):339): 285-299
- Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.CA Cancer J Clin. 2018; 68: 250-281https://doi.org/10.3322/caac.21457
- Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.J Clin Oncol. 2011; 29: 3747-3752https://doi.org/10.1200/JCO.2010.34.0778
- Genetic factors and colorectal cancer in Ashkenazi Jews.Fam Cancer. 2004; 3: 215-221https://doi.org/10.1007/s10689-004-9547-x
- Clinical utility gene card for: MUTYH-associated polyposis (MAP), autosomal recessive colorectal adenomatous polyposis, multiple colorectal adenomas, multiple adenomatous polyps (MAP) - update 2012.Eur J Hum Genet. 2013; 21https://doi.org/10.1038/ejhg.2012.163
- Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysis.Fam Cancer. 2011; 10: 1-9https://doi.org/10.1007/s10689-010-9399-5
National Cancer Institute Surveillance, Epidemiology, and End Results Program. Cancer Statistics. National Cancer Institute. Accessed November 21, 2021. https://seer.cancer.gov/statistics/
- Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence.Gut. 2014; 63: 326-336https://doi.org/10.1136/gutjnl-2012-304121
- Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population.J Clin Oncol. 2015; 33: 2901-2907https://doi.org/10.1200/JCO.2015.61.2408
- Determining the clinical validity of hereditary colorectal cancer and polyposis susceptibility genes using the Clinical Genome Resource Clinical Validity Framework.Genet Med. 2019; 21: 1507-1516https://doi.org/10.1038/s41436-018-0373-1
- Monoallelic MUTYH pathogenic variants ascertained via multi-gene hereditary cancer panels are not associated with colorectal, endometrial, or breast cancer.Fam Cancer. 2022; https://doi.org/10.1007/s10689-021-00285-7
- A systematic review and meta-analysis of familial colorectal cancer risk.Am J Gastroenterol. 2001; 96: 2992-3003https://doi.org/10.1111/j.1572-0241.2001.04677.x